LifeStance Health Group, Inc. (LFST) Reports Q4 Net Loss of $108M

LifeStance Health Group, Inc. (NASDAQ: LFST) reported Q4 net loss of $108 million. Revenue for the quarter came in at $190.1 million versus the consensus estimate of $191.69 million.

GUIDANCE:

LifeStance Health Group, Inc. sees FY2022 revenue of $865-885 million, versus the consensus of $875 million.

For earnings history and earnings-related data on LifeStance Health Group, Inc. (LFST) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Pfizer lung cancer drug misses survival goal in Phase 3 trial